Cargando…
Gliadel wafers in the treatment of malignant glioma: a systematic review
QUESTION: What is the safety and efficacy of interstitial chemotherapy with carmustine-loaded polymers (Gliadel wafers: MGI Pharma, Bloomington, MN, U.S.A.) in the treatment of newly diagnosed or recurrent malignant glioma (that is, glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligoas...
Autores principales: | Perry, J., Chambers, A., Spithoff, K., Laperriere, N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Multimed Inc.
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002480/ https://www.ncbi.nlm.nih.gov/pubmed/17938702 |
Ejemplares similares
-
The use of prophylactic anticonvulsants in patients with brain tumours—a systematic review
por: Perry, J., et al.
Publicado: (2006) -
Management of single brain metastasis: a practice guideline
por: Mintz, A., et al.
Publicado: (2007) -
Interstitial chemotherapy with biodegradable BCNU (Gliadel(®)) wafers in the treatment of malignant gliomas
por: Bota, Daniela A, et al.
Publicado: (2007) -
Canadian recommendations for the treatment of glioblastoma multiforme
por: Mason, W.P., et al.
Publicado: (2007) -
A Multicenter Phase I/II Study of the BCNU Implant (Gliadel (®) Wafer) for Japanese Patients with Malignant Gliomas
por: AOKI, Tomokazu, et al.
Publicado: (2014)